Description:
Comprehensive Insights into the Global Veterinary Diagnostics Market
Kalorama Information’s The World Market for Veterinary Diagnostics, 6th Edition is an extensive market research report providing a detailed analysis of the global veterinary diagnostics market, focused on the performance of its two main segments: companion animal (pets) diagnostics and food animal diagnostics.
Overview
This report offers a thorough examination of major veterinary disease markets and overall market development. It provides valuable data points, including:
- Total Global Animal Diagnostic Testing Market (2022-2027): Market size in millions of dollars at the manufacturer level.
- Global Veterinary Diagnostic Testing Market Share by Region (2022): Analysis for the US, Europe, Latin America, Asia Pacific, and Rest of World (RoW).
- Food Animal Diagnostics Market by Infectious Disease (2022): Breakdown by diseases such as Bovine Viral Diarrhea (BVD), Classical Swine Fever (CSF), Enzootic Bovine Leukosis (EBL), Infectious Bovine Tracheitis (IBR), Porcine Coronavirus Diseases (PEDv, PDCoV, TGE), Porcine Reproductive and Respiratory Syndrome (PRRS), Pseudorabies/Aujeszky’s, Transmissible Spongiform Encephalopathies (TSEs), and others.
- Veterinary Companion Diagnostics Market Segmentation (2022): Including Clinical Chemistry, Molecular Assays and Instruments, Non-Infect Immunodiagnostics, and Other Analyzers and Reagents.
Global Scope
The geographical scope of this report is global, with a focus on key markets such as the United States, Europe, Japan, China, India, Australia, Canada, Brazil, and Mexico. All revenue figures are at the manufacturer’s level in U.S. dollars. The base year for data is 2022, with forecast data from 2022 to 2027. Forecasts are based on demographic trends, new developments, innovative technology, and global expansion.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: Veterinary Food Animal Diagnostics Testing Market Segmentation, 2022 (in millions $)
| Segment | Revenues | Percent Total |
| Clinical Chemistry | $XX Million | XX% |
| Infectious Disease Immunodiagnostics | $XX Million | XX% |
| Non-infect Immunodiagnostics | $XX Million | XX% |
| Molecular Assays and Instruments | $XX Million | XX% |
| Other Analyzers and Reagents | $XX Million | XX% |
| Total | $XX Million | XX% |
Source: Kalorama Information
